Furthermore, studies also found that the overexpression of LIN28B was associated with poor prognosis in head and neck cancer 39, oral squamous cell carcinoma patients 40, 41, gastric cancer 42, breast cancer 43, ovarian cancer 44, and neuroblastoma 16, 45, 46. Here, LIN28B is linked to breast carcinoma.